Description
Research in transfusion medicine is vital to the future of the field and, downstream, to the safety of recipients of transfusion and cellular therapies worldwide. The Emory Center for Transfusion and Cellular Therapies (CTCT) is one of the largest, most comprehensive academic transfusion medicine programs in the nation, with 11 primary faculty members within the Department of Pathology and Laboratory Medicine and 5 adjunct faculty members (with primary appointments outside the Pathology Department). Members of the CTCT are dedicated to excellence in clinical service, outstanding basic, translational and clinical research, and the clinical and research-based training of future leaders in the field.
The present T32 Post-Doctoral Scientist Training Program (HL69769; Training Grant in Transfusion Medicine) was initially funded in 2004 and has been successfully renewed every 5 years since then. John D. Roback, MD PhD is the PI and Program Director. Dr. Roback is a tenured Professor in the Department of Pathology and Laboratory Medicine, Director of the CTCT, Executive Vice-Chair of Clinical Operations for the Department of Pathology and Laboratory Medicine, and Medical Director for Emory Medical Laboratories.
This Program supports the training of 2 Fellows simultaneously, each for a 2-year intensive, highly structured, mentored training program in transfusion medicine- and cell therapy-related research. Thus far, 20 individuals have been appointed to the Program, 13 of whom have received academic faculty appointments upon completion of the Program, and 3 of whom are still in training. Among the graduates of this program, 7 have obtained research funding from sources including NIH, other Federal organizations, private foundations, and corporations. Thus, this Program has already produced many of the current and future national leaders in both the clinical and research aspects of transfusion medicine and cell therapy.